The Curbsiders Internal Medicine Podcast3 Des 2018

#128 Aspirin Overhyped and Overused

Aspirin’ to figure out if ASA can help prevent a heart attack? Interpreting all the new trials doesn’t have to cause chest pain! Join Dr. Ambarish Pandey from UT Southwestern as he helps The Curbsiders ASCEND the mountains of the latest studies to ARRIVE at some well-informed conclusions on the role of aspirin in primary prevention for cardiac events. The team also discusses secondary prevention, aspirin and dual (or triple) antiplatelet therapy, and whether it’s okay to stop giving aspirin to older adults without known CAD (Spoiler alert: it’s okay). ACP members can visit https://acponline.org/curbsiders to claim free CME-MOC credit for this episode and show notes (goes live 0900 EST).

Full show notes available at http://thecurbsiders.com/podcast. Join our mailing list and receive a PDF copy of our show notes every Monday. Rate us on iTunes, recommend a guest or topic and give feedback at thecurbsiders@gmail.com.

Credits

Written and produced by: Justin Berk MD, Matthew Watto MD

CME questions by: Justin Berk MD

Hosts: Matthew Watto MD, Paul Williams MD, Stuart Brigham MD

Edited by: Matthew Watto MD and Chris Chiu MD

Guest: Dr. Ambarish Pandey MD

Time Stamps

00:00 Disclaimer, intro and guest bio
04:15 Guest one liner, book recommendation, career and research advice
11:07 Case of aspirin for primary prevention, aspirin’s public persona, and nocebo effects of statins
21:40 ARRIVE and ASCEND trials
28:14 Aspree trial
32:38 Coronary artery calcium; aspirin use for secondary prevention
37:42 Dual antiplatelet therapy and the DAPT score
41:25 Should we continue aspirin when a patient also needs a DOAC?
46:14 Should we continue DAPT in a patient who needs a DOAC (or warfarin)?
49:40 Deprescribing aspirin for primary prevention in older adults?
50:51 Closing remarks
52:33 Outro

Denne episoden er hentet fra en åpen RSS-feed og er ikke publisert av Podme. Den kan derfor inneholde annonser.

Episoder(500)

#531 2025 ACLS Guideline Updates Live from #SHM #Converge2026

With 10+ parts to the 2025 ACLS guidelines, it’s a lot to sift through. Join us for this focused conversation on the parts that have had most practice changing updates with Dr. Jessica Nave (Emory Uni...

6 Jul 52min

REBOOT: #507 Swinging the Pendulum on Menopause Care With Dr Rachel Rubin

We have another classic episode for you. Transform your approach to menopause care with the latest evidence and expert insights you can use tomorrow. Learn how to move beyond outdated WHI-era fears an...

29 Jun 1h 33min

#530 Nutrition with Dr. Joan Salge Blake

Confidently counsel on nutrition, as we discuss different dietary patterns and address common patient queries. We are joined by Dr. Joan Salge Blake (Boston University).Claim CME for this episode at c...

22 Jun 1h 14min

#529 A Case of Syncope with the Clinical Problem Solvers

Enjoy the ride as we go through a case of syncope with the Clinical Problem Solvers! Listen in awe as they break down their thought process when evaluating a patient presenting with syncope. We are jo...

15 Jun 57min

#528 Hospital Addiction Medicine 3.0 with Dr. Maggie Lowenstein

Become the Medetomi-Dean of AdmissionsStep up your hospital addiction medicine game by learning to troubleshoot methadone dose confirmations/missed doses and understanding how medetomidine’s emergency...

8 Jun 1h 18min

#527 Oncology Potpourri for the Hospitalist

Malignant Bowel Obstruction, VTE and Goals of CareMaster malignant bowel obstruction, cancer-associated thrombosis, and goals-of-care conversations in hospitalized patients with advanced cancer. Learn...

1 Jun 59min

#526 DIGEST – game changers in pancreatic cancer, lipid guideline updates, and GLP-1/GIP endoscopy holds

Join us as we review recent articles and news featured in The DIGEST, including updated lipid guidelines, GLP1 agonists holds and procedures, the newest drug in pancreatic cancer, and discontinuing th...

25 Mai 57min

#525: Multi-Cancer Early Detection Testing

Cut through the hype of Multi-Cancer Early Detection (MCED) tests and learn how to counsel patients on the real-world utility, false-positive risks, and the "stage shift" debate of these emerging bloo...

18 Mai 46min